| Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency (ATALANTa) |
NCT03679598 |
10 |
63 |
Parallel RCT |
2019 |
2023 |
NCATS |
| Cesarean Section Optimal Antibiotic Prophylaxis (C/SOAP) Trial |
NCT01235546 |
14 |
2013 |
Parallel RCT |
2010 |
2015 |
NICHD |
| Chronic Hypertension and Pregnancy (CHAP) Project |
NCT02299414 |
61 |
2408 |
Parallel RCT |
2015 |
2022 |
NHLBI |
| Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS) CombiRx |
NCT00211887 |
71 |
1008 |
Parallel RCT |
2011 |
2015 |
NINDS |
| Molecular Mechanisms of Volume Overload-Aim 1 (SCCOR in Cardiac Dysfunction and Disease) |
NCT01052428 |
1 |
38 |
Parallel RCT |
2005 |
2009 |
NHLBI |
| Myasthenia Gravis Patient Registry |
|
|
|
Registry |
2019 |
2022 |
MGFA |
| Non-Invasive Inhaled Nitric Oxide in Premature Newborns |
NCT00955487 |
5 |
124 |
Parallel RCT |
2007 |
2014 |
NHLBI |
| Overcoming TWEAK Signaling to Restore Muscle and Mobility After Joint Replacement (TWEAK) |
NCT02628795 |
1 |
80 |
Parallel RCT |
2015 |
2019 |
NICHD |
| Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 |
NCT04527471 |
1 |
45 |
Phase II Parallel RCT |
2019 |
2021 |
Verona Pharma |
| Precision High-Intensity Training Through Epigenetics (PHITE) |
NCT03380923 |
1 |
239 |
Parallel RCT |
2016 |
2021 |
Wright State Univ |
| Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex (PREVeNT) Trial |
NCT02849457 |
13 |
84 |
Phase IIb Trial |
2016 |
2023 |
NINDS |
| Secondary Prevention of Small Subcortical Stroke (SPS3) Trial |
NCT00059306 |
65 |
3020 |
2x2 Factorial RCT |
2003 |
2012 |
NINDS |
| Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension |
NCT01409031 |
7 |
3 |
Phase II Parallel RCT |
2010 |
2012 |
NHLBI |
| Thymectomy in Non-Thymomatous MG Patients on Prednisone (MGTX) |
NCT00294658 |
70 |
126 |
Parallel RCT |
2005 |
2015 |
NINDS |